Skip to main content
Clinical Trials/NCT05091125
NCT05091125
Not yet recruiting
Not Applicable

Diagnostic Performance of the S100B Protein in the Prognosis of Patients With Mild Head Trauma With Risk of Complications in Patients Over 65 Years Old.

University Hospital, Strasbourg, France0 sites300 target enrollmentNovember 2, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild Head Trauma With Risk of Complications
Sponsor
University Hospital, Strasbourg, France
Enrollment
300
Primary Endpoint
The threshold of the S100B protein
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

For patients with mild head trauma, a large number of CT scans are performed. The S100B protein allows, when the dosage is below the threshold, to rule out the diagnosis of brain damage with a negative predictive value of 98%.

In patients over 65 years old it was found that the dosage of S100B came back positive more often compared to a younger population.

This study proposes to determine the positivity threshold value for S100B dosage in patients over 65 years old. In patients over 65 years suffering from mild head trauma, a head CT will systematically be performed (in accordance with the recommendations) and the S100B will be measured (taken from an additional tube on the blood test carried out in these patients). The results of the TDM will then be compared with the results of the S100B to determine the values of sensitivity, specificity, negative and positive predictive value of different thresholds.

Registry
clinicaltrials.gov
Start Date
November 2, 2021
End Date
November 2, 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female aged 65 or more
  • Patients going to the emergency for a mild head trauma with risk of complication and treated within 3 hours of the head injury, according to the following criteria:
  • Adult patients with head trauma presenting:
  • Retrograde amnesia lasting more than 30 min, Or
  • A loss of consciousness or amnesia of the facts Or
  • Glasgow score \<15 to 2 hours from traumatism
  • Speaking and reading French
  • Subject having expressed his non-opposition to the research or non-opposition given by a trusted person / member of his family in cases where the patient is not in a position to express his non-opposition.
  • Subject affiliated to a social health insurance protection scheme

Exclusion Criteria

  • Severe head trauma
  • Mild head trauma without risk of complication
  • Patient under the protection of justice
  • Patient under guardianship, curatorship
  • Subject in exclusion period (determined by a previous or current study)

Outcomes

Primary Outcomes

The threshold of the S100B protein

Time Frame: This outcome measure is assessed on Day 1.

Secondary Outcomes

  • - Sensitivity (Se) and Specificity (Sp) of the S100B protein in the differential diagnosis of bleeding - Positive predictive value and negative predictive value of the S100B protein in the differential diagnosis of hemorrhage(This outcome measure is assessed on Day 1.)

Similar Trials